Medicines Company Sells Three Heart Meds to Italy's Chiesi

The company divests Cleviprex, Kengreal and rights to Argatroban for Injection to Chiesi USA Inc.

May 11, 2016

Related

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

Celltrion to buy US biologics manufacturing plant as part of tariff response strategy

Editor’s (re)View: Trump’s on-again, off-again pharma tariffs are getting old

Editor’s (re)View: Trump’s on-again, off-again pharma tariffs are getting old

OnTrak Wireless: Total Bearing Health Solution

Sponsored

OnTrak Wireless: Total Bearing Health Solution

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified

Trending

CDMOs in China and US are forecast to see fastest growth: analysis

Lilly to invest $1.2B in Puerto Rico facility to boost US oral medicine manufacturing

Biopharma’s manufacturing agility wanes amid supply chain resilience: survey

Sponsored Picks

Sponsored

OnTrak Wireless: Total Bearing Health Solution

Sponsored

Early Intervention with OnTrak Wireless for High-Heat Environments

Sponsored

OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified